Abstract
The central nervous system is endowed with complex mechanisms of defense. However, these protection mechanisms fail in the presence of risk factors such as genetic mutations, environmental factors (bisphenol A, polycyclic aromatic hydrocarbons (PAHs), polyfluoroalkyl chemicals) or social stress and psychiatric disorders (anxiety, depression, psychosis, attention deficits) appear. Critical psychiatric conditions treatment consists in administration of antidepressants and antipsychotics drugs. These drugs are widely prescribed, but their efficiency in controlling mental symptoms is an important point in current clinical studies.
Antidepressants and antipsychotics register several side effects and their interactions with other polycyclic aromatic hydrocarbons are well established. Research is focused upon reducing these side effects and understanding their pharmacodynamic and pharmacokinetic properties in order to develop advanced methods to predict induced pharmacological events. Here we intend to detail recent advances in the field of structure-activity relationship (QSAR) applied to antidepressants and antipsychotics with polycyclic aromatic structure as last generation drugs used in central nervous system disorders. We present the biological activity of large series of psychiatric drugs predicted by 2D and 3D-QSAR dependent and independent molecules alignment. Predicted biological activities were correlated with common pharmaceutical descriptors as steric, electronic hydrogen donor/acceptor bond but also new components of QSAR models as membrane ions’ contributions to the antagonism of these drugs at membrane receptors are presented. The paper refers both to preclinical tested molecules and to already known antidepressants and antipsychotics based on a large variety of polycyclic aromatic structure. Drug potency decrease in the presence of PAHs is also discussed.
Keywords: Antidepressants, Antipsychotics, Membrane receptors, Polycyclic aromatic structure, QSAR, Pharmaceutical descriptors.
Current Organic Chemistry
Title:Advanced QSAR Methods Evaluated Polycyclic Aromatic Compounds Duality as Drugs and Inductors in Psychiatric Disorders
Volume: 17 Issue: 23
Author(s): Speranta Avram, Maria Mernea, Dan Mihailescu, Daniel Duda-Seiman and Corina Duda-Seiman
Affiliation:
Keywords: Antidepressants, Antipsychotics, Membrane receptors, Polycyclic aromatic structure, QSAR, Pharmaceutical descriptors.
Abstract: The central nervous system is endowed with complex mechanisms of defense. However, these protection mechanisms fail in the presence of risk factors such as genetic mutations, environmental factors (bisphenol A, polycyclic aromatic hydrocarbons (PAHs), polyfluoroalkyl chemicals) or social stress and psychiatric disorders (anxiety, depression, psychosis, attention deficits) appear. Critical psychiatric conditions treatment consists in administration of antidepressants and antipsychotics drugs. These drugs are widely prescribed, but their efficiency in controlling mental symptoms is an important point in current clinical studies.
Antidepressants and antipsychotics register several side effects and their interactions with other polycyclic aromatic hydrocarbons are well established. Research is focused upon reducing these side effects and understanding their pharmacodynamic and pharmacokinetic properties in order to develop advanced methods to predict induced pharmacological events. Here we intend to detail recent advances in the field of structure-activity relationship (QSAR) applied to antidepressants and antipsychotics with polycyclic aromatic structure as last generation drugs used in central nervous system disorders. We present the biological activity of large series of psychiatric drugs predicted by 2D and 3D-QSAR dependent and independent molecules alignment. Predicted biological activities were correlated with common pharmaceutical descriptors as steric, electronic hydrogen donor/acceptor bond but also new components of QSAR models as membrane ions’ contributions to the antagonism of these drugs at membrane receptors are presented. The paper refers both to preclinical tested molecules and to already known antidepressants and antipsychotics based on a large variety of polycyclic aromatic structure. Drug potency decrease in the presence of PAHs is also discussed.
Export Options
About this article
Cite this article as:
Avram Speranta, Mernea Maria, Mihailescu Dan, Duda-Seiman Daniel and Duda-Seiman Corina, Advanced QSAR Methods Evaluated Polycyclic Aromatic Compounds Duality as Drugs and Inductors in Psychiatric Disorders, Current Organic Chemistry 2013; 17 (23) . https://dx.doi.org/10.2174/13852728113179990132
DOI https://dx.doi.org/10.2174/13852728113179990132 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Chemistry and Biology of Carbohydrates
Carbohydrates are one of the most abundant natural products and are considered to be extremely important biomolecules for their ever-increasing impact on chemistry and biology. Their role in several important biological processes, notably energy storage, transport, modulation of protein function, intercellular adhesion, malignant transformation, signal transduction, viral, and bacterial cell ...read more
Electrochemical C-X bond formation
Conventional methods for carrying out carbon–X bond formation are typically conducted at harsh reaction conditions, and rely on expensive catalysts as well as the use of stoichiometric, and perhaps toxic, oxidants. In this regard, electrochemical synthesis has recently been recognized as a sustainable and scalable strategy for the construction of ...read more
From Lab Bench to Algorithm: The Future of Organic Chemistry Powered by AI
Organic chemistry, with its intricate dance of molecules and reactions, is undergoing a transformation fuelled by the power of Artificial Intelligence (AI) and Machine Learning (ML). The integration of AI/ML with Organic Chemistry is revolutionizing the field by enhancing the efficiency and accuracy of chemical research and development. These technologies ...read more
Related Journals
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Potential Therapeutic Strategies of Phytochemicals in Neurodegenerative Disorders
Current Topics in Medicinal Chemistry GDNF Family Ligands: A Potential Future for Parkinson's Disease Therapy
CNS & Neurological Disorders - Drug Targets The Chemical Biology of Immunophilin Ligands
Current Medicinal Chemistry Cognitive Impairment and Dementia in Patients with Parkinson Disease
Current Topics in Medicinal Chemistry Adenosine A2A-D2 Receptor-Receptor Interactions in Putative Heteromers in the Regulation of the Striato-Pallidal GABA Pathway: Possible Relevance for Parkinson`s Disease and its Treatment
Current Protein & Peptide Science New Molecular Avenues in Parkinson ’ s Disease Therapy
Current Topics in Medicinal Chemistry Regulation of Dopamine Signaling in the Striatum by Phosphodiesterase Inhibitors: Novel Therapeutics to Treat Neurological and Psychiatric Disorders
Central Nervous System Agents in Medicinal Chemistry TRPV1 Channel: A Potential Drug Target for Treating Epilepsy
Current Neuropharmacology Antidepressant Related Movement Disorders in the Elderly
Current Psychiatry Reviews The Role of Melatonin in Multiple Sclerosis, Huntington's Disease and Cerebral Ischemia
CNS & Neurological Disorders - Drug Targets 5'-Nucleotidases, Nucleosides and their Distribution in the Brain: Pathological and Therapeutic Implications
Current Medicinal Chemistry Pharmacotherapy of Schizophrenia: The Past, Present and Future
Current Drug Therapy Treating Schizophrenia: Novel Targets for the Cholinergic System
CNS & Neurological Disorders - Drug Targets Susceptibility Genes for the Side Effect of Antipsychotics on Body Weight and Obesity
Current Drug Targets Mesenchymal Cells in the Treatment of Spinal Cord Injury: Current & Future Perspectives
Current Stem Cell Research & Therapy Analysis of Flavin-Containing Monooxygenase 3 Genotype Data in Populations Administered the Anti-Schizophrenia Agent Olanzapine
Drug Metabolism Letters Caffeine: Cognitive and Physical Performance Enhancer or Psychoactive Drug?
Current Neuropharmacology Improving Red Blood Cell K-Uptake and its Impact on O2/CO2 Exchange, and NO-Generation in Microvascular CHD: A Novel Therapeutic Approach
Recent Patents on Cardiovascular Drug Discovery Central Nervous System Depressants and Risk of Hospitalization due to Community-Acquired Pneumonia in very Old Patients
Current Drug Safety In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson’s Disease
Current Neuropharmacology